4 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 4 separate news trends connected to Car-T Therapy, spanning August 18, 2026 through September 15, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 36 article observations and 36 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
14 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Novartis and Bristol Myers have halted autoimmune CAR-T trials after three patient deaths.
Novartis and Bristol Myers have paused CAR-T trials after patient deaths, raising safety concerns in the biopharma industry.
A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.